# Dr. Ajit Bapurao Nalawade – FDA Inspection, Oct 27, 2023

Source: https://www.keypedia.com/records/fda_inspections/dr-ajit-bapurao-nalawade/526ec69c-901e-4a59-a294-8c2bff8b21e7
Source feed: FDA_Inspections

> FDA inspection 1221658 of Dr. Ajit Bapurao Nalawade, October 27, 2023. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221658
- Company Name: Dr. Ajit Bapurao Nalawade
- Inspection Date: 2023-10-27
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- Issuing Officer
- [Company Rep](https://www.keypedia.com/people/tawny-l-colling/4ce51467-468c-4271-a98d-4b13c15c0812)

Company: https://www.keypedia.com/companies/dr-ajit-bapurao-nalawade/8f9ebcae-947e-4f2e-aeed-446b996de044

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c